Figure 6
From: Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment
Immune-related analysis between high-risk and low-risk groups. (A) The immune infiltration of immune cell types in high-risk and low-risk patients in the TCGA-CRC cohort. (B) Analysis of immune functions in high-risk and low-risk patients in the TCGA-CRC cohort. (C) High-risk and low-risk CRC patients with TIDE scores in the TCGA-CRC cohort. *p < 0.05, **p < 0.01, ***p < 0.001.
